Early Treatment with Anti-VLA-4 mAb Can Prevent the Infiltration and/or Development of Pathogenic CD11b+CD4+ T Cells in the CNS during Progressive EAE.
Mindur JE, Ito N, Dhib-Jalbut S, Ito K
PLoS One. 2014; 9(6):e99068. Epub 2014 Jun 04. PMID: 24896098.Abstract